FIBROBLAST GROWTH FACTOR 21: A POWERFUL THERAPEUTIC FOR HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS

被引：0
|
作者：
Liu, C. [1 ,2 ]
Schonke, M. [1 ,2 ]
Zhou, E. [1 ,2 ]
Li, Z. [1 ,2 ]
Kooijman, S. [1 ,2 ]
Larsson, M. [3 ]
Wallenius, K. [3 ]
Peng, X. -R. [3 ]
Wang, Y. [1 ,2 ,4 ]
Rensen, P. [1 ,2 ,4 ]
机构：
[1] Leiden Univ, Med Ctr, Div Endocrinol, Dept Med, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands
[3] AstraZeneca, Imed Biotech Unit, Cardiovasc Renal & Metab, Gothenburg, Sweden
[4] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China
来源：
ATHEROSCLEROSIS | 2020年 / 315卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
768
引用
收藏
页码：E16 / E17
页数：3
相关论文
共 50 条
  • [21] Fibroblast growth factor 21 in metabolic syndrome
    Yang, Ming
    Liu, Chongbin
    Jiang, Na
    Liu, Yan
    Luo, Shilu
    Li, Chenrui
    Zhao, Hao
    Han, Yachun
    Chen, Wei
    Li, Li
    Xiao, Li
    Sun, Lin
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [22] Effects of fibroblast growth factor 21 on the heart
    Tanajak, Pongpan
    Chattipakorn, Siriporn C.
    Chattipakorn, Nipon
    JOURNAL OF ENDOCRINOLOGY, 2015, 227 (02) : R13 - R30
  • [23] Fibroblast growth factor 21 in heart failure
    William Tucker
    Bradley Tucker
    Kerry-Anne Rye
    Kwok Leung Ong
    Heart Failure Reviews, 2023, 28 : 261 - 272
  • [24] Fibroblast Growth Factor 21 in Patients with Acromegaly
    Halupczok-Zyla, Jowita
    Jawiarczyk-Przybylowska, Aleksandra
    Skrzypski, Marek
    Strowski, Mathias Z.
    Bolanowski, Marek
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2017, 125 (10) : 649 - 654
  • [25] Fibroblast growth factor 21 and bone homeostasis
    Tang, Yan
    Zhang, Mei
    BIOMEDICAL JOURNAL, 2023, 46 (04)
  • [26] Fibroblast growth factor 21 in heart failure
    Tucker, William
    Tucker, Bradley
    Rye, Kerry-Anne
    Ong, Kwok Leung
    HEART FAILURE REVIEWS, 2023, 28 (01) : 261 - 272
  • [27] Therapeutic utilities of fibroblast growth factor 19
    Wu, Xinle
    Li, Yang
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (11) : 1307 - 1316
  • [28] Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk
    Jin, Leigang
    Lin, Zhuofeng
    Xu, Aimin
    DIABETES & METABOLISM JOURNAL, 2016, 40 (01) : 22 - 31
  • [29] Relationship of fibroblast growth factor 21 with kidney function and albuminuria: multi-ethnic study of atherosclerosis
    Anuwatmatee, Sahapab
    Allison, Matthew A.
    Shlipak, Michael G.
    McClelland, Robyn L.
    Kramer, Holly
    Tang, Shudi
    Hou, Liming
    Rye, Kerry-Anne
    Ong, Kwok Leung
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (06) : 1009 - 1016
  • [30] Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
    Yang Xiao
    Lingjiao Liu
    Aimin Xu
    Pengcheng Zhou
    Zhaofeng Long
    Yiting Tu
    Xiaoyan Chen
    Weili Tang
    Gan Huang
    Zhiguang Zhou
    Cardiovascular Diabetology, 14
12345